Expression and activation of the steroidogenic enzyme CYP11A1 is associated with IL-13 production in T cells from peanut allergic children.
Adolescent
Aminoglutethimide
/ pharmacology
Cell Line
Child
Child, Preschool
Cholesterol Side-Chain Cleavage Enzyme
/ antagonists & inhibitors
Enzyme Activation
/ drug effects
Female
Gene Knockout Techniques
Humans
Interleukin-13
/ biosynthesis
Lymphocyte Activation
Male
Peanut Hypersensitivity
/ blood
RNA, Messenger
/ genetics
Th2 Cells
/ immunology
Transfection
Young Adult
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
03
01
2020
accepted:
07
05
2020
entrez:
5
6
2020
pubmed:
5
6
2020
medline:
22
8
2020
Statut:
epublish
Résumé
Activation of the steroidogenic enzyme CYP11A1 was shown to be necessary for the development of peanut-induced intestinal anaphylaxis and IL-13 production in allergic mice. We determined if levels of CYP11A1 in peripheral blood T cells from peanut-allergic (PA) children compared to non-allergic controls were increased and if levels correlated to IL-13 production and oral challenge outcomes to peanut. CYP11A1 mRNA and protein levels were significantly increased in activated CD4+ T cells from PA patients. In parallel, IL-13 production was significantly increased; IFNγ levels were not different between groups. There were significant correlations between expression levels of CYP11A1 mRNA and levels of IL13 mRNA and protein, levels of serum IgE anti-Ara h 2 and to outcomes of peanut challenge. The importance of CYP11A1 on cytokine production was tested using a CYP11A1 CRISPR/Cas9 KO plasmid or an inhibitor of enzymatic CYP11A1 activity. Inhibition of CYP11A1 activation in patient cells treated with the inhibitor, aminoglutethimide, or CD4+ T cell line transfected with the CYP11A1 KO plasmid resulted in reduced IL-13 production. These data suggest that the CYP11A1-CD4+Tcell-IL-13 axis in activated CD4+ T cells from PA children is associated with development of PA reactions. CYP11A1 may represent a novel target for therapeutic intervention in PA children.
Identifiants
pubmed: 32497050
doi: 10.1371/journal.pone.0233563
pii: PONE-D-20-00239
pmc: PMC7272076
doi:
Substances chimiques
IL13 protein, human
0
Interleukin-13
0
RNA, Messenger
0
Aminoglutethimide
0O54ZQ14I9
Cholesterol Side-Chain Cleavage Enzyme
EC 1.14.15.6
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0233563Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
J Allergy Clin Immunol. 2001 Jan;107(1):191-3
pubmed: 11150011
J Allergy Clin Immunol. 2018 Mar;141(3):991-1001
pubmed: 29030101
Exp Biol Med (Maywood). 2009 Aug;234(8):880-907
pubmed: 19491374
Allergy. 2013 Feb;68(2):220-8
pubmed: 23253182
J Clin Invest. 2003 Nov;112(9):1437-43
pubmed: 14597769
J Allergy Clin Immunol. 2014 Feb;133(2):291-307; quiz 308
pubmed: 24388012
J Clin Invest. 2003 Apr;111(7):1065-72
pubmed: 12671056
J Allergy Clin Immunol. 1997 Oct;100(4):444-51
pubmed: 9338535
Clin Exp Allergy. 2001 Jul;31(7):1031-5
pubmed: 11467993
J Allergy Clin Immunol. 2000 Jul;106(1 Pt 1):53-6
pubmed: 10887305
Lancet. 2001 Dec 1;358(9296):1871-2
pubmed: 11741628
J Immunol Methods. 1995 Dec 15;188(1):117-28
pubmed: 8551029
Int Arch Allergy Immunol. 2014;165(3):179-94
pubmed: 25531161
J Allergy Clin Immunol. 2012 Dec;130(6):1260-74
pubmed: 23195525
J Allergy Clin Immunol. 2010 Aug;126(2):306-16, 316.e1-12
pubmed: 20624645
Mol Cell Endocrinol. 2011 Apr 10;336(1-2):80-4
pubmed: 21195129
Exp Mol Med. 2018 Apr 16;50(4):20
pubmed: 29657326
FASEB J. 1999 May;13(8):893-901
pubmed: 10224232
Endocrinology. 2003 Oct;144(10):4285-8
pubmed: 12959982
Mol Endocrinol. 2008 Apr;22(4):915-23
pubmed: 18174359
Clin Exp Allergy. 2005 Mar;35(3):268-73
pubmed: 15784102
Endocrinology. 2001 Aug;142(8):3519-29
pubmed: 11459798
J Allergy Clin Immunol. 2010 Jul;126(1):92-7.e5
pubmed: 20538332
J Allergy Clin Immunol. 2013 Nov;132(5):1174-1183.e8
pubmed: 23870673
Cell Rep. 2014 May 22;7(4):1130-42
pubmed: 24813893
J Exp Med. 2004 Dec 20;200(12):1635-46
pubmed: 15596520
Nat Commun. 2016 Jan 11;7:10213
pubmed: 26750596
Nat Rev Immunol. 2016 Dec;16(12):751-765
pubmed: 27795547
Proc Natl Acad Sci U S A. 2013 May 14;110(20):8152-7
pubmed: 23630275
N Engl J Med. 2015 Feb 26;372(9):803-13
pubmed: 25705822
Ann Allergy Asthma Immunol. 2008 Mar;100(3 Suppl 3):S1-148
pubmed: 18431959
Mol Endocrinol. 2007 Apr;21(4):948-62
pubmed: 17213386
J Immunol. 2007 Dec 1;179(11):7406-14
pubmed: 18025184